In situ and invasive lobular neoplasia of the breast

Histopathology

Volumn 52, Issue 1, 2008, Pages 58-66

  Hanby, A M ^a   Hughes, T A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Atypical lobular hyperplasia; Invasive lobular carcinoma; Lobular carcinoma in situ; Lobular neoplasia

Indexed keywords

BREAST TUMOR; CANCER INVASION; CARCINOMA IN SITU; CYTOGENETICS; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; MOLECULAR GENETICS; MORPHOLOGY; PATHOLOGY; PRIORITY JOURNAL; REVIEW;

BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; FEMALE; HUMANS; HYPERPLASIA;

EID: 37249079705     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02891.x     Document Type: Review

References (78)

1. Wellings SR, Jensen HM, Marcum RG. Atlas of subgross pathology of the human breast with special reference to possible cancerous lesions. J. Natl Cancer Inst. 1975 55 231 273.
2. Hanby AM. Aspects of molecular phenotype and its correlations with breast cancer behaviour and taxonomy. Br. J. Cancer 2005 92 613 617.
3. Pritt B, Ashikaga T, Oppenheimer RG, Weaver DL. Influence of breast cancer histology on the relationship between ultrasound and pathology tumor size measurements. Mod. Pathol. 2004 17 905 910.
4. Wheeler DT, Tai LH, Bratthauer GL, Waldner DL, Tavassoli FA. Tubulolobular carcinoma of the breast: an analysis of 27 cases of a tumor with a hybrid morphology and immunoprofile. Am. J. Surg. Pathol. 2004 28 1587 1593.
5. Bratthauer GL, Moinfar F, Stamatakos MD et al. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum. Pathol. 2002 33 620 627.
6. Wenzel C, Bartsch R, Hussian D et al. Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF. Breast Cancer Res. Treat. 2007 104 109 114.
7. Turashvili G, Bouchal J, Baumforth K et al. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 2007 7 55.
8. Savanis G, Simatos G, Tzaida O et al. Gastrointestinal tract metastasis as first presentation of breast cancer. J BUON 2006 11 79 81.
9. Kadivar M, Joulaee A, Kashkouli MB, Kharazi HH, Kalantari M, Kumar PV. Orbital metastasis as the first presentation of nonpalpable invasive lobular carcinoma of the breast. Breast J. 2006 12 75 76.
10. Giagounidis AA, Heinsch M, von Barany RU, Erlemannb R, Aul C. Breast cancer metastasis to the aortic vessel wall. Onkologie 2005 28 369.
11. El Khoury M, Cherel P, Becette V et al. Unusual soft-tissue metastasis of an invasive lobular carcinoma mimicking fasciitis. Am. J. Roentgenol. 2004 182 745 747.
12. Li CI, Anderson BO, Porter P, Holt SK, Daling JR, Moe RE. Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer 2000 88 2561 2569.
13. Li CI, Daling JR, Malone KE et al. Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer. Cancer Epidemiol. Biomarkers Prev. 2006 15 946 954.
14. Lakhani SR, Audretsch W, Cleton-Jensen AM et al. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)? Eur. J. Cancer 2006 42 2205 2211.
15. Li CI, Malone KE, Saltzman BS, Daling JR. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Cancer 2006 106 2104 2112.
16. Urban JA. Bilaterality of cancer of the breast. Biopsy of the opposite breast. Cancer 1967 20 1867 1870.
17. Rosen PP, Senie R, Schottenfeld D, Ashikari R. Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment. Ann. Surg. 1979 189 377 382.
18. Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun DW Jr. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am. J. Surg. Pathol. 1978 2 225 251.
19. Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD Jr., Simpson JF. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 2003 361 125 129.
20. Marshall LM, Hunter DJ, Connolly JL et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol. Biomarkers Prev. 1997 6 297 301.
21. Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 2004 6 R149 R156.
22. Krecke KN, Gisvold JJ. Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. Am. J. Roentgenol. 1993 161 957 960.
23. Ma L, Fishell E, Wright B, Hanna W, Allan S, Boyd NF. Case-control study of factors associated with failure to detect breast cancer by mammography. J. Natl Cancer Inst. 1992 84 781 785.
24. Kepple J, Layeeque R, Klimberg VS et al. Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. Am. J. Surg. 2005 190 623 627.
25. Cornford EJ, Wilson AR, Athanassiou E et al. Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analysis. Br. J. Radiol. 1995 68 450 453.
26. Helvie MA, Paramagul C, Oberman HA, Adler DD. Invasive lobular carcinoma. Imaging features and clinical detection. Invest. Radiol. 1993 28 202 207.
27. Weinstein SP, Orel SG, Heller R et al. MR imaging of the breast in patients with invasive lobular carcinoma. Am. J. Roentgenol. 2001 176 399 406.
28. Boetes C, Veltman J, van Die L, Bult P, Wobbes T, Barentsz JO. The role of MRI in invasive lobular carcinoma. Breast Cancer Res. Treat. 2004 86 31 37.
29. Munot K, Dall B, Achuthan R, Parkin G, Lane S, Horgan K. Role of magnetic resonance imaging in the diagnosis and single-stage surgical resection of invasive lobular carcinoma of the breast. Br. J. Surg. 2002 89 1296 1301.
30. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978 42 737 769.
31. Leibl S, Regitnig P, Moinfar F. Flat epithelial atypia (DIN 1a, atypical columnar change): an underdiagnosed entity very frequently coexisting with lobular neoplasia. Histopathology 2007 50 859 865.
32. Abdel-Fatah TM, Powe DG, Hodi Z, Lee AH, Reis-Filho JS, Ellis IO. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am. J. Surg. Pathol. 2007 31 417 426.
33. Foote FW, Stewart FW. Lobular carcinoma in situ. Am. J. Pathol. 1941 491 495.
34. Mohsin SK, O'Connell P, Allred DC, Libby AL. Biomarker profile and genetic abnormalities in lobular carcinoma in situ. Breast Cancer Res. Treat. 2005 90 249 256.
35. Rudas M, Neumayer R, Gnant MF, Mittelbock M, Jakesz R, Reiner A. p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast. Eur. J. Cancer 1997 33 39 44.
36. Somerville JE, Clarke LA, Biggart JD. c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma. J. Clin. Pathol. 1992 45 16 20.
37. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer: I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991 19 403 410.
38. NHSBSP Publication Number 58. Pathology reporting of breast disease. Sheffield : NHS Cancer Screening Programmes and The Royal College of Pathologists, 2005.
39. Singletary SE, Patel-Parekh L, Bland KI. Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base. Ann. Surg. 2005 242 281 289.
40. Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW. Pathological prognostic factors in breast cancer: II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 1992 20 479 489.
41. Martinez V, Azzopardi JG. Invasive lobular carcinoma of the breast: incidence and variants. Histopathology 1979 3 467 488.
42. Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer 1975 36 1 85.
43. Roylance R, Gorman P, Harris W et al. Comparative hybridisation of breast tumours stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res. 1999 59 1433 1436.
44. Nishizaki T, Chew K, Chu L et al. Genomic alterations in lobular breast cancer by comparative genomic hybridization. Int. J. Cancer 1997 74 513 517.
45. Radhi JM. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR. Histopathology 2000 36 156 160.
46. Middleton LP, Palacios DM, Bryant BR, Krebs P, Otis CN, Merino MJ. Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am. J. Surg. Pathol. 2000 24 1650 1656.
47. Walford N, Ten Velden J. Histiocytoid breast carcinoma: an apocrine variant of lobular carcinoma. Histopathology 1989 14 515 522.
48. Fisher ER, Gregorio RM, Redmond C, Fisher B. Tubulolobular invasive breast cancer: a variant of lobular invasive cancer. Hum. Pathol. 1977 8 679 683.
49. Marchio C, Sapino A, Arisio R, Bussolati G. A new vision of tubular and tubulo-lobular carcinomas of the breast, as revealed by 3-D modelling. Histopathology 2006 48 556 562.
50. du Toit RS, Locker AP, Ellis IO, Elston CW, Nicholson RI, Blamey RW. Invasive lobular carcinomas of the breast - the prognosis of histopathological subtypes. Br. J. Cancer 1989 60 605 609.
51. Pereira H, Pinder SE, Sibbering DM et al. Pathological prognostic factors in breast cancer: IV. Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology 1995 27 219 226.
52. Kuroda H, Tamaru J, Takeuchi I et al. Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast. Virchows Arch. 2006 448 500 505.
53. Buerger H, Simon R, Schafer KL et al. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol. Pathol. 2000 53 118 121.
54. Berx G, Cleton-Jansen AM, Strumane K et al. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996 13 1919 1925.
55. Leeuw WJFd, Berx G, Vos CBJ et al. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J. Pathol. 1997 183 404 411.
56. Moll R, Mitze M, Frixen U, Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am. J. Pathol. 1993 142 987 993.
57. Vos CBJ, Cleton-Jansen AM, Berx G et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br. J. Cancer 1997 76 1131 1133.
58. Berx G, Nollet F, Roy FV. Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas. Cell Adhes. Commun. 1998 6 171 184.
59. Berx G, Cleton-Jansen AM, Nollet F et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 1995 14 6107 6115.
60. Huiping C, Sigurgeirsdottir J, Jonasson J et al. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer. Br. J. Cancer 1999 81 1103 1110.
61. Droufakou S, Deshmane V, Hanby A, Tomlinson I, Hart I. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int. J. Cancer 2001 92 404 408.
62. Rasbridge SA, Gillett CE, Sampson SA, Walsh FS, Millis RR. Epithelial (E-) and Placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J. Pathol. 1993 169 245 250.
63. Boller K, Vestweber D, Kemler R. Cell adhesion molecule uvomorulin is localised in the intermediate junctions of the adult intestinal epithelial cells. J. Cell Biol. 1985 100 327 332.
64. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991 251 1451 1455.
65. Gumbiner B, Stevenson B, Grimaldi A. The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J. Cell Biol. 1988 107 1575 1587.
66. Droufakou S, Deshmane V, Roylance R, Hanby A, Tomlinson I, Hart IR. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int. J. Cancer 2001 92 404 408.
67. Salomon D, Sacco PA, Roy SG et al. Regulation of β-catenin levels and the localisation by overexpression of plakoglobin and inhibition of the Ubiquitin-Proteosome system. J. Cell Biol. 1997 139 1325 1335.
68. Simcha I, Shtutman M, Salomon D et al. Differential nuclear translocation and transactivation potential of β-catenin and plakoglobin. J. Cell Biol. 1998 141 1433 1448.
69. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B. Activation of β-catenin-Tcf signalling in colon cancer by mutations in β-catenin or APC. Science 1997 275 1787 1790.
70. Shtutman M, Zhurinsky J, Simcha I et al. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl Acad. Sci. U.S.A. 1999 96 5522 5527.
71. Gillett CE, Miles DW, Ryder K et al. Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast. J. Pathol. 2001 193 433 441.
72. Tan DSP, Potts HWW, Leong ACK et al. The biological and prognostic significance of cell polarity and E-cadherin in grade I infiltrating ductal carcinoma of the breast. J. Pathol. 1999 189 20 27.
73. Vos C, Haar Nt, Rosenberg C et al. Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type. Br. J. Cancer 1999 81 1410 1418.
74. Roylance R, Gorman P, Papior T et al. A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH. Oncogene 2006 25 6544 6553.
75. Reis-Filho JS, Simpson PT, Jones C et al. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J. Pathol. 2005 207 1 13.
76. Reis-Filho JS, Simpson PT, Turner NC et al. FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Clin. Cancer Res. 2006 12 6652 6662.
77. Elbauomy Elsheikh S, Green AR, Lambros MB et al. FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis. Breast Cancer Res. 2007 9 R23.
78. Keller G, Vogelsang H, Becker I et al. Diffuse gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am. J. Pathol. 1999 155 337 342.